Catalyst Wire Dossier Catalyst Wire Dossier

MK-7625A

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-7625A, covering 2021-12-01 to 2021-12-21. Get the full timeline:

Most recent: Clinical Trial Update: MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035) [Phase 2]

See pricing